This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
My career started as an RGN, and I continue to work in the NHS in renal medicine. I’ve worked in the pharmaceutical industry full-time for 24 years across a variety of roles but mostly within Leadership and Market Access, and latterly heading up KeyAccountManagement at Boehringer-Ingelheim.
In the context of a new medical innovation where there is a high unmet patient need, this means patients are not getting rapid access to medicines that can positively impact or even extend their lives. Prescription medicine companies simply have fewer ways of reaching audiences at scale compared to nearly any other industry.
Companies that adopt this blended model will be able to recognise performance gaps earlier and, for the first time, align incentives across the entire commercial ecosystem, including sales reps, keyaccountmanagers, and medical science liaisons.”. Content automation will deliver as AI fails to live up to the hype.
Focusing on the law: “Regulators moved quickly to simplify rules across the clinical trial supply chain…the use of public transport to move people, and postal services to move medicinal products around the country has been adopted,” according to Ievgenii Volynets, head of commercial legal at international clinical trial logistics provider Oximio.
Takeda Connect provides oncologists with information about their KeyAccountManager and Medical Science Liaison, alongside direct access at the click of a button. Beyond personalising content, creating a tailored channel experience is also vitally important. About the author.
It’s not about changing the way prescribers practice medicine. Click To Tweet What I will tell you is that changing somebody’s prescribing habits and changing the way they practice medicine are two different skillsets. I’m not going to be able to message you to change the way you manage a patient population.
The need for quality When it comes to injectable medicine, achieving product sterility through aseptic manufacturing is of critical importance. In August 2022, a final revision of the EU GMP Annex 1 was released stressing the importance of a holistic contamination control strategy in the manufacture of sterile medicinal products.
We’re also thinking of a solution for how to transfer medicine and investigational medical products for our clients to the people that need them,” explains Olga Vizgalova, managing director for Ukraine at Oximio. But it doesn’t end there. “We’re Credit: Oximio.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content